Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 May;77(9):1508–1513. doi: 10.1038/bjc.1998.248

Hypertension, obesity and their medications in relation to renal cell carcinoma.

J M Yuan 1, J E Castelao 1, M Gago-Dominguez 1, R K Ross 1, M C Yu 1
PMCID: PMC2150191  PMID: 9652770

Abstract

A population-based, case-control study was conducted in Los Angeles County, California, to investigate the inter-relationships of obesity, hypertension and medications in relation to renal cell carcinoma (RCC) risk. A total of 1204 RCC patients and an equal number of neighbourhood controls were included. Obesity was a strong risk factor for RCC. A fourfold increase in risk was observed for those with usual body mass index (kg m(-2)) of > or = 30 vs < 22. A history of hypertension was another strong, independent risk factor for RCC [odds ratio (OR) = 2.2; 95% confidence interval (CI) = 1.8, 2.6]. There was little evidence that use of diuretics was directly related to RCC development. Use of diuretics for reasons other than hypertension (primarily for weight control) was unrelated to risk among self-reported normotensive subjects (OR = 1.2; 95% CI = 0.7, 2.2). Among hypertensive subjects, heavy users of diuretics experienced similar risk as light users (OR = 0.9 among subjects with lifetime dose of > or = 137 g compared with those with lifetime dose of < 43 g). Similarly, normotensive subjects who took non-diuretic antihypertensives regularly showed no increased risk for RCC (OR = 1.1; 95% CI = 0.6-1.8), and intake among hypertensive subjects did not further increase their risk. Regular use of amphetamine-containing diet pills was associated with a twofold increase in RCC risk (95% CI = 1.4-2.8) and the risk increased with increasing dose of amphetamines. However, the fraction of cases possibly related to this exposure is small (population-attributable risk = 5%).

Full text

PDF
1508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chow W. H., McLaughlin J. K., Mandel J. S., Wacholder S., Niwa S., Fraumeni J. F., Jr Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):17–21. [PubMed] [Google Scholar]
  2. Eng E., Veniant M., Floege J., Fingerle J., Alpers C. E., Menard J., Clozel J. P., Johnson R. J. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens. 1994 Feb;7(2):177–185. doi: 10.1093/ajh/7.2.177. [DOI] [PubMed] [Google Scholar]
  3. Finkle W. D., McLaughlin J. K., Rasgon S. A., Yeoh H. H., Low J. E. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control. 1993 Nov;4(6):555–558. doi: 10.1007/BF00052431. [DOI] [PubMed] [Google Scholar]
  4. Grove J. S., Nomura A., Severson R. K., Stemmermann G. N. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol. 1991 Nov 1;134(9):942–947. doi: 10.1093/oxfordjournals.aje.a116178. [DOI] [PubMed] [Google Scholar]
  5. Heath C. W., Jr, Lally C. A., Calle E. E., McLaughlin J. K., Thun M. J. Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol. 1997 Apr 1;145(7):607–613. doi: 10.1093/oxfordjournals.aje.a009157. [DOI] [PubMed] [Google Scholar]
  6. Hiatt R. A., Tolan K., Quesenberry C. P., Jr Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control. 1994 Jul;5(4):319–325. doi: 10.1007/BF01804982. [DOI] [PubMed] [Google Scholar]
  7. Keane W. F., Kasiske B. L., O'Donnell M. P., Kim Y. Hypertension, hyperlipidemia, and renal damage. Am J Kidney Dis. 1993 May;21(5 Suppl 2):43–50. doi: 10.1016/0272-6386(93)70094-f. [DOI] [PubMed] [Google Scholar]
  8. Kreiger N., Marrett L. D., Dodds L., Hilditch S., Darlington G. A. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control. 1993 Mar;4(2):101–110. doi: 10.1007/BF00053150. [DOI] [PubMed] [Google Scholar]
  9. Mai M., Geiger H., Hilgers K. F., Veelken R., Mann J. F., Dämmrich J., Luft F. C. Early interstitial changes in hypertension-induced renal injury. Hypertension. 1993 Nov;22(5):754–765. doi: 10.1161/01.hyp.22.5.754. [DOI] [PubMed] [Google Scholar]
  10. McLaughlin J. K., Blot W. J., Fraumeni J. F., Jr Diuretics and renal cell cancer. J Natl Cancer Inst. 1988 May 4;80(5):378–378. doi: 10.1093/jnci/80.5.378. [DOI] [PubMed] [Google Scholar]
  11. McLaughlin J. K., Chow W. H., Mandel J. S., Mellemgaard A., McCredie M., Lindblad P., Schlehofer B., Pommer W., Niwa S., Adami H. O. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 1995 Oct 9;63(2):216–221. doi: 10.1002/ijc.2910630212. [DOI] [PubMed] [Google Scholar]
  12. Mellemgaard A., Lindblad P., Schlehofer B., Bergström R., Mandel J. S., McCredie M., McLaughlin J. K., Niwa S., Odaka N., Pommer W. International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int J Cancer. 1995 Jan 27;60(3):350–354. doi: 10.1002/ijc.2910600313. [DOI] [PubMed] [Google Scholar]
  13. O'Donnell M. P., Kasiske B. L., Kim Y., Schmitz P. G., Keane W. F. Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis. 1993 Jul;22(1):83–89. doi: 10.1016/s0272-6386(12)70172-5. [DOI] [PubMed] [Google Scholar]
  14. Raynor W. J., Jr, Shekelle R. B., Rossof A. H., Maliza C., Paul O. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am J Epidemiol. 1981 Apr;113(4):371–377. doi: 10.1093/oxfordjournals.aje.a113105. [DOI] [PubMed] [Google Scholar]
  15. Ron E., Kleinerman R. A., Boice J. D., Jr, LiVolsi V. A., Flannery J. T., Fraumeni J. F., Jr A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987 Jul;79(1):1–12. [PubMed] [Google Scholar]
  16. Weinmann S., Glass A. G., Weiss N. S., Psaty B. M., Siscovick D. S., White E. Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol. 1994 Nov 1;140(9):792–804. doi: 10.1093/oxfordjournals.aje.a117328. [DOI] [PubMed] [Google Scholar]
  17. Yu M. C., Mack T. M., Hanisch R., Cicioni C., Henderson B. E. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst. 1986 Aug;77(2):351–356. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES